BIO-PATH HLDGS IN.DL-,001 Aktie Logo
US09057N4097
A403XM

BIO-PATH HLDGS IN.DL-,001 Aktie

Loading quotes...

Forecast

Buy
  5
Hold
  0
Sell
  0

  • Bio-Path Holdings moves headquarters to Wyoming and creates Series S preferred shares

    Bio-Path Holdings approved the move of its headquarters to Wyoming and filed an amendment to its charter to create a new class of Series S preferred shares consisting of 51 shares, each convertible into one common share and representing 1% of diluted voting power. The company also appointed Wendy M. Charles and Michael Hickey to a newly formed scientific advisory board; both received three-year contracts and were granted 100,000 stock options each with an exercise price of $0.06. The information comes from a filing with the SEC. » More on de.investing.com

Financials

In the last quarter, BIO-PATH HLDGS IN.DL-,001 Aktie had revenue of €0 and net profit of -€2.31M
(EUR) June 2026
YoY
Revenue 0 -
Gross profit 0 100.00%
Net profit -2.31M 40.78%
EBITDA -821.01K 78.60%

Fundamentals

Metric Value
Market capitalization
€147.93K
Number of shares
9.34M
52-week high/low
€0.11 - €0.00861
Dividends No
Beta
-0.50
P/E ratio
-0.07
PEG ratio
0.00
P/B ratio
-0.06
P/S ratio
0.00

Company profile

Name
BIO-PATH HLDGS IN.DL-,001 Aktie
CEO
Vikram Paul Grover
Employees 1
🍪

Parqet  uses cookies. Learn more